Sydney: February 22, 2013 – Parker & Partners (P&P), the public affairs arm of Ogilvy Public Relations Australia, has expanded its offering in health with a new addition to the team.
Arli Miller joins P&P immediately in the role of Associate Director based in Sydney. Arli brings strong expertise and connections across the healthcare industry, particularly with the pharmaceutical industry, health consumer groups, policy makers, peak bodies and advocacy groups. She is charged with providing strategic public affairs council to organisations across the spectrum of Australia’s health and pharmaceutical sectors.
“Arli is a great addition to the team,” said Mathew Jones, Managing Director, Parker & Partners. “Having worked within the pharmaceutical industry for many years, Arli’s appointment offers current and prospective clients an enviable level of understanding and insight into the complex health policy and regulatory environment.
“Arli’s appointment complements P&P’s already renowned public affairs expertise in heath including policy, reimbursement and regulatory strategies, issues and crisis management, company credentialing, product, therapy and disease-state profiling, stakeholder engagement and policy and government market analysis,” he said.
Arli brings to P&P a wealth of knowledge in health, having worked most recently within the pharmaceutical and NGO sector. Most recently she worked at Eli Lilly Australia (Lilly) and GlaxoSmithKline in the Corporate Affairs functions. Prior to her work in the pharmaceutical industry Arli headed the media and communication function at MS Australia – the peak body representing the interests of people living with multiple sclerosis.
Whilst at Lilly, Arli developed a number of innovative stakeholder engagement programs, including a program to encourage consumer engagement in health technology assessment. She was also an enthusiastic member of the Medicines Australia Health Consumer Organisation Working Group and is still an active participant within the Health Technology Australia partnership.
“As the pharmaceutical sector has become more highly regulated and scrutinised, it’s vital that practitioners have both the right connections and relationships and the strategic know-how and creativity to help drive clients’ agendas forward,” Mr Jones said.
“Arli has both of those attributes in spades, and we’re looking forward to the value she will bring to new and prospective clients.”
Ogilvy Public Relations is a joint venture between WPP and STW Group, Australia’s leading marketing content and communication services group.